triazoles has been researched along with Black Fever in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Coelho, EAF; Coimbra, ES; Cunha-Júnior, EF; da Silva, AD; das Chagas Almeida, A; Glanzmann, N; Leal, YL; Meinel, RS; Melo, RCN; Mendonça, DVC; Perin, L; Silva, TP | 1 |
| Ballard, J; Be, C; Berman, A; Biggart, A; Bursulaya, B; Caridha, D; Chen, YL; Chianelli, D; Davis, LC; Eggimann, FK; Gao, MY; Gibney, M; Glynne, RJ; Groessl, T; Hein, A; Jiricek, J; Johnson, K; Khare, S; Kreishman-Deitrick, M; Lai, YH; Lerario, I; Liang, F; Liu, X; Luneau, A; Mathison, CJN; Molteni, V; Nagle, A; Pybus, B; Rao, SPS; Richmond, W; Rudewicz, PJ; Sciotti, RJ; Shapiro, M; Smith, J; Spraggon, G; Srinivas, H; Supek, F; Thompson, C; Tuntland, T; Wiesmann, C; Xie, Y; Yeh, V | 1 |
| Gupta, S; Kant, P; Kumar, S; Mittal, M; Shivahare, R; Suryawanshi, SN; Tiwari, A | 1 |
| Bloomer, WD; Kaiser, M; Papadopoulou, MV; Rosenzweig, HS; Wilkinson, SR | 1 |
| Blonski, C; Diez-Martinez, A; Jagu, E; Krauth-Siegel, RL; Labruère, R; Loiseau, PM; Pethe, S; Pomel, S; Ramiandrasoa, F | 1 |
| Al-Abdely, HM; Graybill, JR; Loebenberg, D; Melby, PC | 1 |
6 other study(ies) available for triazoles and Black Fever
| Article | Year |
|---|---|
Functionalized 1,2,3-triazolium salts as potential agents against visceral leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Dogs; Leishmania infantum; Leishmaniasis, Visceral; Mice; Mice, Inbred BALB C; Salts; Triazoles | 2022 |
Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases.
Topics: Animals; Antiprotozoal Agents; Dogs; Humans; Leishmania donovani; Leishmania major; Leishmaniasis, Visceral; Liver; Macaca fascicularis; Mice; Mice, Inbred BALB C; Oxazoles; Proteasome Inhibitors; Pyrimidines; Rats; Rats, Sprague-Dawley; Triazoles | 2020 |
Chemotherapy of leishmaniasis. Part XII: design, synthesis and bioevaluation of novel triazole integrated phenyl heteroterpenoids as antileishmanial agents.
Topics: Animals; Antiparasitic Agents; Chlorocebus aethiops; Dose-Response Relationship, Drug; Drug Design; Leishmania donovani; Leishmaniasis, Visceral; Molecular Structure; Parasitic Sensitivity Tests; Structure-Activity Relationship; Terpenes; Triazoles; Vero Cells | 2013 |
Novel nitro(triazole/imidazole)-based heteroarylamides/sulfonamides as potential antitrypanosomal agents.
Topics: Amides; Apoptosis; Blood Platelets; Cells, Cultured; Chagas Disease; Flow Cytometry; Heterocyclic Compounds; Humans; Imidazoles; In Vitro Techniques; Leishmania donovani; Leishmaniasis, Visceral; Molecular Structure; Monocytes; Platelet Activation; Sulfonamides; Triazoles; Trypanocidal Agents; Trypanosoma cruzi | 2014 |
Synthesis and in vitro antikinetoplastid activity of polyamine-hydroxybenzotriazole conjugates.
Topics: Animals; Antiprotozoal Agents; Humans; Leishmania donovani; Leishmaniasis, Visceral; NADH, NADPH Oxidoreductases; Spermidine; Triazoles; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 2017 |
Efficacy of the triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous and visceral leishmaniases.
Topics: Amphotericin B; Animals; Fluconazole; Leishmania donovani; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Liver; Lymph Nodes; Male; Mice; Mice, Inbred BALB C; Spleen; Time Factors; Triazoles; Trypanocidal Agents | 1999 |